- Products
- Reproduction
- Molecular diagnostics
- Careers
- About us
- Contacts
Bladder cancer is the 5th most common type of cancer in men and the 14th in women in the Czech Republic. Unfortunately, this tumor has a high tendency to return, which is why patients are monitored after treatment using unpleasant procedures such as cystoscopy.
The Bladder EpiRcheck test can replace a cystoscopy examination. It is based on the detection of methylation of selected biomarkers by analyzing DNA isolated from urine using the Real-Time PCR method.
Data analysis is completely automatic.
The test is CE-IVD certified.
You can find more information about the product HERE.
For more information, please contact us by e-mail: diagnostika@pentagen.cz